Des-gamma-carboxy prothrombin and proliferative activity of hepatocellular carcinoma
Taketoshi Suehiro(Kyushu University), Keizo Sugimachi(Kyushu University), Hidetoshi Itasaka(Kyushu University), Takashi Matsumata(Kyushu University), Akinobu Taketomi(Hokkaido University), Kazuhiro Yamamoto(Max Planck Institute for Gravitational Physics)
Cited by 53
Related Papers
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244